temozolomide

NDC 75834-132 · Nivagen Pharmaceuticals, Inc.

Generic nametemozolomide

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TEMOZOLOMIDE

Strength5 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

75834-132-05 — 1 BOTTLE in 1 CARTON (75834-132-05) / 5 CAPSULE in 1 BOTTLE

75834-132-14 — 1 CARTON in 1 CARTON (75834-132-14) / 1 CAPSULE in 1 CARTON

FDA lists these products with the same active ingredient.

72162-2661 — Temozolomide, 72162-2662 — Temozolomide, 72162-2663 — Temozolomide, 72162-2664 — Temozolomide, 73043-011 — Temozolomide, 73043-012 — Temozolomide, 73043-013 — Temozolomide, 73043-014 — Temozolomide, 73043-015 — Temozolomide, 73043-016 — Temozolomide, 75834-142 — temozolomide, 75834-143 — temozolomide, 75834-144 — temozolomide, 75834-145 — temozolomide, 75834-146 — temozolomide, 82249-404 — Temozolomide, 82249-406 — Temozolomide, 82249-408 — Temozolomide, 82249-410 — Temozolomide, 82249-412 — Temozolomide, +50 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.